Cancer Research UK logo.
SearchDonate
  • Search

A study of relatlimab and nivolumab for certain types of advanced cancer (CA224020)

Overview

Cancer types:

Melanoma, Secondary cancers

Status:

Closed

Phase:

Phase 1/2

Details

This study is looking at a new drug called relatlimab to see how well it works alongside nivolumab for certain types of advanced cancer. It is for people whose cancer has spread elsewhere in the body and/or it can’t be removed by surgery.

Recruitment start: 14 December 2016

Recruitment end: 30 July 2021

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr James Larkin

Supported by

Bristol-Myers Squibb

Last reviewed: 25 May 2022

CRUK internal database number: 15385

Help and support